RecallHawk

PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE)

WYETH PHARMS

Summary

FDA approved PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) by WYETH PHARMS. NDA (New Drug) approval (Labeling) on 2025-04-22. TABLET, ORAL-28.

Details

Source

Drug Approval

External ID

NDA020527-67

Action Date

2025-04-22

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

PREMPRO (generic: CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE), TABLET, ORAL-28. Application: NDA020527

Context & Analysis

WYETH PHARMS has 4 FDA actions in our database.

Frequently Asked Questions

How often does WYETH PHARMS have FDA actions?

WYETH PHARMS has 4 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA020527-67" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions